| 06/02/2026 5:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 11:26 AM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/21/2026 3:48 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2026 3:52 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/01/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 12:08 PM | Quest Diagnostics (1022079) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 1:39 PM | Quest Diagnostics (1022079) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 4:22 PM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/27/2026 3:17 PM | Quest Diagnostics (1022079) Subject | Form FWP | |
| 04/27/2026 7:47 AM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
Get the Latest News and Ratings for DGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/24/2026 5:23 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:12 PM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/21/2026 5:48 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 3:32 PM | Quest Diagnostics (1022079) Filer | Form DEF 14A | |
| 04/06/2026 3:33 PM | Quest Diagnostics (1022079) Filer | Form DEFA14A | |
| 04/02/2026 4:16 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 10:36 AM | Quest Diagnostics (1022079) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/11/2026 5:03 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/11/2026 5:05 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 10:53 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:55 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:43 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 3:37 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:37 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:37 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
I was right about SpaceX (Ad) Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it.
In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day. See how to claim your stake in SpaceX before the public can |
| 03/04/2026 3:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 11:53 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 11:12 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 10:52 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 1:21 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/20/2026 4:06 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:07 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:08 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:09 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:13 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 9:34 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:19 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:23 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 11:46 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 5:53 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:37 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 3:30 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 3:30 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 3:24 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/25/2025 8:42 AM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 10:02 AM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/07/2025 3:29 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 1:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/21/2025 5:50 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2025 5:31 AM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/30/2025 3:36 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/26/2025 3:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/25/2025 3:39 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 3:10 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2025 3:14 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2025 3:27 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 3:34 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 11:10 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/15/2025 4:22 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad) Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history.
CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500. See how to get positioned in SpaceX before the announcement goes public |
| 08/15/2025 4:25 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/15/2025 4:29 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/08/2025 3:40 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2025 12:54 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/31/2025 1:27 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/25/2025 3:25 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/25/2025 3:26 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/25/2025 3:26 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/25/2025 3:27 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |